Tag: trending OOS results

Writing Impact Assessments for OOS Events in Pharma Stability

📝 Introduction to OOS Impact Assessments Out-of-Specification (OOS) results in pharmaceutical stability studies can trigger critical reviews and regulatory attention. One of the most crucial parts of OOS handling is writing a comprehensive impact assessment that justifies your conclusion and ensures data integrity. An impact assessment answers the essential question: “Does this OOS result affect…

Deviation and OOS Handling in Stability Testing, Pharmaceutical Quality and Practices

Regulatory Guidelines for Reporting OOS in Stability Studies

Out-of-Specification (OOS) results in stability studies are critical indicators that a pharmaceutical product may no longer meet its intended quality attributes. Regulatory agencies across the globe, including the USFDA, EMA, and CDSCO, have strict requirements for how these deviations should be identified, investigated, and reported. This article provides a comprehensive look at the regulatory framework…

Deviation and OOS Handling in Stability Testing, Pharmaceutical Quality and Practices

Deviation and OOS Handling in Stability Testing: A GMP-Compliant Approach

Deviation and OOS Handling in Stability Testing: A GMP-Compliant Approach Deviation and OOS Handling in Stability Testing: A GMP-Compliant Approach Introduction Stability testing in pharmaceuticals ensures that drug products maintain their identity, strength, quality, and purity over time. However, deviations and out-of-specification (OOS) results may occur during these studies due to numerous factors such as…

Deviation and OOS Handling in Stability Testing, Pharmaceutical Quality and Practices